phenylbutazone

Key facts

INN

phenylbutazone

Brand

AZOLID

Route

ORAL

Formulation

CAPSULE

Related patents

patent

US 11542275

Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11365205

Imidazolidin-2-one compounds as PRMT5 modulators

Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10709692

Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1

Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10544113

Thiazolidinone compounds and use thereof

Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione deriva

Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8637560

Imidazolidinone compounds, methods to inhibit deubiquitination and methods of tr

Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8283370

Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and

Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is phenylbutazone?

phenylbutazone (AZOLID), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for phenylbutazone?

AZOLID is a marketed brand name for phenylbutazone. Check FDA Drugs@FDA for the current US label holder.